Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Che Hsu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
New Biotechnology|September 28, 2015
Development of a magnetic bead-based method for the collection of circulating extracellular vesiclesChun-Liang Shih, Kowit-Yu Chong, Shih-Che Hsu, et al.
Kidney International|January 22, 2010
Testosterone increases urinary calcium excretion and inhibits expression of renal calcium transport proteinsYu-Juei Hsu, Henrik Dimke, Joost P H Schoeber, et al.
Journal of Molecular and Cellular Cardiology|June 21, 2015
CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremiaChih-Yuan Lin, Yu-Juei Hsu, Shih-Che Hsu, et al.
International Journal of Cardiology|November 23, 2016
Sirtuin 1 protects the aging heart from contractile dysfunction mediated through the inhibition of endoplasmic reticulum stress-mediated apoptosis in cardiac-specific Sirtuin 1 knockout mouse modelYu-Juei Hsu, Shih-Che Hsu, Chiao-Po Hsu, et al.
Life (Basel, Switzerland)|February 25, 2022
The Role of Sirtuin 1 in Palmitic Acid-Induced Endoplasmic Reticulum Stress in Cardiac MyoblastsHsiang-Yu Yang, Jhao-Ying Chen, Yen-Nien Huo, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2022
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac FunctionMartina Arici, Mara Ferrandi, Paolo Barassi, et al.
Journal of Translational Medicine|January 19, 2024
Selective SERCA2a activator as a candidate for chronic heart failure therapyMartina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Medicinal Chemistry|May 17, 2022
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart FailureAndrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Drug Design, Development and Therapy|March 16, 2026
Dexmedetomidine Use and Intraoperative Bradycardia During Radiofrequency Rhizotomy for Trigeminal Neuralgia: A Retrospective Observational StudyChen-Hsi Tang, Shao-Chun Wu, Chung-Ming Yu, et al.
Cardiovascular Research|April 1, 2021
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathyEleonora Torre, Martina Arici, Alessandra Maria Lodrini, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
New Biotechnology|September 28, 2015
Development of a magnetic bead-based method for the collection of circulating extracellular vesiclesChun-Liang Shih, Kowit-Yu Chong, Shih-Che Hsu, et al.
Kidney International|January 22, 2010
Testosterone increases urinary calcium excretion and inhibits expression of renal calcium transport proteinsYu-Juei Hsu, Henrik Dimke, Joost P H Schoeber, et al.
Journal of Molecular and Cellular Cardiology|June 21, 2015
CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremiaChih-Yuan Lin, Yu-Juei Hsu, Shih-Che Hsu, et al.
International Journal of Cardiology|November 23, 2016
Sirtuin 1 protects the aging heart from contractile dysfunction mediated through the inhibition of endoplasmic reticulum stress-mediated apoptosis in cardiac-specific Sirtuin 1 knockout mouse modelYu-Juei Hsu, Shih-Che Hsu, Chiao-Po Hsu, et al.
Life (Basel, Switzerland)|February 25, 2022
The Role of Sirtuin 1 in Palmitic Acid-Induced Endoplasmic Reticulum Stress in Cardiac MyoblastsHsiang-Yu Yang, Jhao-Ying Chen, Yen-Nien Huo, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2022
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac FunctionMartina Arici, Mara Ferrandi, Paolo Barassi, et al.
Journal of Translational Medicine|January 19, 2024
Selective SERCA2a activator as a candidate for chronic heart failure therapyMartina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Journal of Medicinal Chemistry|May 17, 2022
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart FailureAndrea Luraghi, Mara Ferrandi, Paolo Barassi, et al.
Drug Design, Development and Therapy|March 16, 2026
Dexmedetomidine Use and Intraoperative Bradycardia During Radiofrequency Rhizotomy for Trigeminal Neuralgia: A Retrospective Observational StudyChen-Hsi Tang, Shao-Chun Wu, Chung-Ming Yu, et al.
Cardiovascular Research|April 1, 2021
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathyEleonora Torre, Martina Arici, Alessandra Maria Lodrini, et al.
Pageof 3